|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities | |||||
| Depreciation and amortization of property, equipment and software | |||||
| Amortization of line of credit issuance costs | |||||
| Accretion of discount on marketable securities | |||||
| Amortization of acquired intangible assets | |||||
| Amortization of deferred commissions | |||||
| Amortization of right-of-use operating lease asset | |||||
| Stock-based compensation expense | |||||
| Provision for accounts receivable allowances | |||||
| Loss on lease termination - net | |||||
| Gain on lease modification | |||||
| Accretion Expense | |||||
| Other | |||||
| Changes in operating assets and liabilities, excluding impact from business acquisition | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Deferred commissions | |||||
| Accounts payable and accrued expenses | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Expenditures for property and equipment | |||||
| Payments for business acquisition, net of cash acquired | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturity of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Borrowings from line of credit | |||||
| Repayments of line of credit | |||||
| Payments for line of credit issuance costs | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from employee stock purchase plan | |||||
| Proceeds From Disgorgement of Stockholder Short-Swing Profits | |||||
| Employee taxes paid related to the net share settlement of stock-based awards | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents | |||||
| Beginning of year | |||||
| End of year | |||||
| Supplemental cash flow information | |||||
| Cash paid for interest | |||||
| Income Taxes Paid, Net | |||||
| Fair value of contingent consideration in connection with business acquisition | |||||
| Deferred consideration in connection with business acquisition | |||||
| ROU asset obtained in exchange for operating lease liability | |||||
| Non-cash adjustment to operating lease right-of-use assets from lease modifications | |||||
| Capital expenditures incurred but not yet paid | |||||
| Stock-based Compensation Expense Capitalized In Internal-use Software | |||||
| Cash and cash equivalents | |||||
| Restricted Cash | |||||
Loading...